An experimental PET scan was used to detect elevated levels of abnormal tau protein in regions of the brain affected by CTE in living former NFL players.
Researchers have demonstrated that cerebral organoids grown at the air–liquid interface are able to generate nerve tracts and stimulate muscle output; these could be used to improve understanding of neurological diseases such as dementia.
A recently published study has indicated that electrostimulation can help boost elder people’s mental scores to those of people 20–30 years younger.
Researchers have determined that CGRP exhibits pain effects in a sex-specific manner. Understanding these sex-specific differences could help us understand why migraines are three-times more common in women than in men.
Scientists have 3D printed a transparent skull implant for mice, creating a ‘window’ to the brain for monitoring brain surface activity in real time. The implant could provide unique opportunities for research into concussions as well as Alzheimer’s and Parkinson’s diseases.
Researchers have suggested that inducing jet lag in fruit fly models of Huntington’s disease may have a neuroprotective benefit.
A team of neuroscientists has identified a group of cells in the hippocampus that can control fear memories. Understanding the mechanisms by which these cells activate and suppress memories could improve therapies for fear-based disorders.
A recently published study has provided evidence that could potentially aid reports into dogs detecting an epileptic seizure odor.
Researchers have identified adult hippocampal neurogenesis (AHN) in people up to the age of 97 and have noted that ADH gradually declines in people with Alzheimer’s disease.
Biogen and Eisai have announced the decision to discontinue the global Phase III trials of aducanumab for Alzheimer’s disease.